Dec 22, 2017   SOURCE: PR NewsWire

United States Extracorporeal Membrane Oxygenation Machines Markets 2017-2018

DUBLIN, Dec. 22, 2017 /PRNewswire/ --

The "US Market Report for Extracorporeal Membrane Oxygenation Machines 2018 - MedCore" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The ECMO market includes disposable products and capital equipment. ECMO products have been in the market for a long time but have only recently started gaining traction. ECMO has experienced a reinvigoration due to positive reports and the stagnation of heart-lung machines in the market. The market is expected to grow as more surgeons view the technique as a better alternative to heart-lung machines.

Extracorporeal membrane oxygenation (ECMO) is used as a support device for use in heart failure. ECMO is a miniaturized and simplified form of heart-lung machines. ECMO involves withdrawing venous blood with an active pump and returning oxygenated blood into a major central artery. ECMO is primarily used for patients who need cardiac and lung support.

ECMO is divided into three types: veno-arterial (VA), veno-venous (VV) and arteriovenous (AV). VA is used for support during cardiac failure. The blood is drained from a large central vein, into an oxygenator and re-enters the arterial system at the aorta. VA is generally done as a bridge to left ventricular assist device replacement. VV is the most common mode of ECMO done and is generally utilized for support during respiratory failure. VV is not used for cardiac failure and is a bridge to lung transplant.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Coronary Artery Disease
2.1.2 Myocardial Infarction
2.1.3 Angina Pectoris
2.1.4 Heart Valve Disease
2.1.5 Congestive Heart Failure

3. Product Portfolio
3.1.1 Tissue Heart Valves
3.1.2 Mechanical Tissue Heart Valves
3.1.3 Annuloplasty Repair Devices
3.1.4 Transcatheter Aortic Valve Replacement Devices
3.1.5 Transcatheter Mitral Valve Repair Devices
3.1.6 On-Pump Coronary Artery Bypass Devices
3.1.7 Off-Pump Coronary Artery Bypass Devices
3.1.8 Endoscopic Vessel Harvesting Devices
3.1.9 Anastomosis Assist Devices
3.1.10 Transmyocardial Revascularization Devices
3.1.11 Ventricular Assist Devices
3.1.12 Intra-Aortic Balloon Pump Device
3.1.13 Temporary Artificial Heart Replacement Device
3.1.14 Remote Hemodynamic Monitoring System Devices
3.1.15 Patent Foramen Ovale Devices
3.1.16 Atrial & Ventricular Septal Defect Device
3.1.17 Left Atrial Appendage Closure Device
3.1.18 Extracorporeal Membrane Oxygenation Machine
3.2 Fda Recalls
3.2.1 Maquet
3.2.2 Medtronic
3.2.3 Heartware Inc
3.3 Clinical Trials

4. Extracorporeal Membrane Oxygenation Machine Market
4.1 Introduction
4.2 Market Analysis And Forecast
4.3 Drivers And Limiters
4.4 Competitive Market Share Analysis

Companies Mentioned 

    --  Edwards Lifesciences
    --  St. Jude Medical
    --  Medtronic
    --  Maquet
    --  Abiomed
    --  HeartWare Inc.
    --  Sorin Group
    --  Terumo
    --  Abbott Laboratories
    --  Teleflex Medical
    --  Cardiac Assist
    --  AtriCure
    --  W.L. Gore
    --  SynCardia
    --  Boston Scientific
    --  Cryolife
    --  Berlin Heart
    --  Cardica
    --  Chase Medical
    --  Genesee Biomedical
    --  Karl Storz
    --  LifeNet Health
    --  Microline Surgical
    --  Novadaq
    --  On-X
    --  Saphena Medical
    --  SentreHeart
    --  Vitalitec

For more information about this report visit https://www.researchandmarkets.com/research/b7h9st/united_states?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-extracorporeal-membrane-oxygenation-machines-markets-2017-2018-300574916.html

SOURCE Research and Markets